(Q44754094)

English

Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer

scientific article published in February 2004

Statements

Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer (English)
1 February 2004
316-323

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit